Changes in executive remuneration- implications for your business
In the wake of the GFC, the Labor Government's proposed reforms in the Corporations Amendment (Improving Accountability on Director and Executive Remuneration) Bill (Bill) has now been passed by both houses of parliament. The government's stated intention is to make boards more accountable to shareholders.
Key changes came into effect on 1 July 2011. These have a significant impact on the remuneration of directors and key management personnel of listed companies and on AGMs for FY11 and beyond.
Key changes include:
the introduction of the “two strike” rule in relation to the remuneration report
restrictions on the ability of key management personnel to vote on the remuneration report
new rules that apply when appointing a remuneration consultant
restrictions on hedging equity-based remuneration.
This legislation is intended to increase transparency and accountability in executive remuneration matters. Please click here to view a summary of the legislative changes which will effect executive remuneration for reporting entities and listed companies, or here to view a checklist that will uncover just how ready your Board is for this new legislation.
On the 20 September 2011, Lis Boyce presented a seminar on this topic with guest speaker Trevor Bourne, Chairman of Hastie Group Ltd. Please click here for to view the presentation.
13 Nov 2013
A new Guide for Life Science Company Directors was recently launched to support and enhance the performance of boards of directors leading public and private life science companies. Partner Lis Boyce chaired the task force of experienced industry representatives which prepared the Guide.
26 Sep 2013
DibbsBarker has acted for Regeneus Ltd (RGS) in the first listing of a biotechnology company on the Australian Securities Exchange since 2011.
27 Aug 2013
DibbsBarker is pleased to announce the appointment of Melissa McGrath and Jamie Palmer to the partnership.